Peri-implantitis and extracellular matrix antibodies: A case–control study

ABSTRACT

Objective: The aim of this case–control study was to compare patients with a healthy peri-implant environment and patients affected by peri-implantitis, evaluating the occurrence of antibodies to extracellular matrix (ECM) molecules. The authors hypothesized the presence of ECM autoantibodies in serum of peri-implantitis patients. Materials and Methods: Patients were divided into two groups: one with dental implants with a diagnosis of peri-implantitis and one control group with implants classified as being “healthy.” Enzyme-linked immunosorbent assay was performed on patients' sera to detect human antibodies to type I, III, IV, and V collagens, laminin, and fibronectin. Fisher exact test was performed to evaluate statistical association, with a significant P < 0.05. Results: Forty-two patients were enrolled in this study, 27 females (64.28%) and 15 males (35.72%) with a mean age of 53 ± 29.69 years (age range 32–74). The presence of antibodies to CIII was recorded in 6/21 (28.57%) patients of test group, compared to just 2/21 (9.52%) for the control group, showing a statistically significant difference (P < 0.05). Other antibodies tested were found to be not statistically significant or absent. Conclusions: Within the limitations of this study, it can be concluded that further studies, with larger sample and different design, are necessary to address the research purpose, evaluating possible associations between anti-ECM antibodies and peri-implantitis.

Key words:

Collagen - enzyme-linked immunosorbent assay - extracellular matrix - peri-implantitis

• REFERENCES

• 1 Albrektsson T, Donos N. Working Group. Implant survival and complications. The Third EAO consensus conference 2012. Clin Oral Implants Res 2012; 23 (Suppl. 06) 63-5
• 2 Shibli JA, Pires JT, Piattelli A, Iezzi G, Mangano C, Mangano F. et al. Impact of different implant surfaces topographies on peri-implant tissues: An update of current available data on dental implants retrieved from human jaws. Curr Pharm Biotechnol 2017; 18: 76-84
• 3 Brauner E, Guarino G, Jamshir S, Papi P, Valentini V, Pompa V. et al. Evaluation of highly porous dental implants in postablative oral and maxillofacial cancer patients: A prospective pilot clinical case series report. Implant Dent 2015; 24: 631-7
• 4 Eick S, Kindblom C, Mizgalska D, Magdon A, Jurczyk K, Sculean A. et al. Adhesion of Porphyromonas gingivalis and Tannerella forsythia to dentin and titanium with sandblasted and acid etched surface coated with serum and serum proteins-An in vitro study. Arch Oral Biol 2017; 75: 81-8
• 5 Peixoto CD, Almas K. The implant surface characteristics and peri-implantitis. An evidence-based update. Odontostomatol Trop 2016; 39: 23-35
• 6 Koodaryan R, Hafezeqoran A. Evaluation of implant collar surfaces for marginal bone loss: A systematic review and meta-analysis. Biomed Res Int 2016 2016; 4987526
• 7 Cicciù M, Matacena G, Signorino F, Brugaletta A, Cicciù A, Bramanti E. Relationship between oral health and its impact on the quality life of Alzheimer's disease patients: A supportive care trial. Int J Clin Exp Med 2013; 6: 766-72
• 8 Doornewaard R, Christiaens V, De Bruyn H, Jacobsson M, Cosyn J, Vervaeke S. et al. Long-Term effect of surface roughness and patients' factors on crestal bone loss at dental implants. A systematic review and meta-analysis. Clin Implant Dent Relat Res 2017; 19: 372-99
• 9 Benic GI, Bernasconi M, Jung RE, Hämmerle CH. Clinical and radiographic intra-subject comparison of implants placed with or without guided bone regeneration: 15-year results. J Clin Periodontol 2017; 44: 315-25
• 10 De Angelis F, Papi P, Mencio F, Rosella D, Di Carlo S, Pompa G. Implant survival and success rates in patients with risk factors: Results from a long-term retrospective study with a 10 to 18 years follow-up. Eur Rev Med Pharmacol Sci 2017; 21: 433-7
• 11 Sendyk DI, Rovai ES, Pannuti CM, Deboni MC, Sendyk WR, Wennerberg A. Dental implant loss in older versus younger patients: A systematic review and meta-analysis of prospective studies. J Oral Rehabil 2017; 44: 229-36
• 12 Salvi GE, Cosgarea R, Sculean A. Prevalence and mechanisms of peri-implant diseases. J Dent Res 2017; 96: 31-7
• 13 Lindhe J, Meyle J. Group D of European Workshop on Periodontology. Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol 2008; 35 (Suppl. 08) 282-5
• 14 Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant diseases. J Clin Periodontol 2008; 35 (Suppl. 08) 286-91
• 15 Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol 2015; 42 (Suppl. 16) S158-71
• 16 Mencio F, De Angelis F, Papi P, Rosella D, Pompa G, Di Carlo S. A randomized clinical trial about presence of pathogenic microflora and risk of peri-implantitis: Comparison of two different types of implant-abutment connections. Eur Rev Med Pharmacol Sci 2017; 21: 1443-51
• 17 Ata-Ali J, Candel-Marti ME, Flichy-Fernández AJ, Peñarrocha-Oltra D, Balaguer-Martinez JF, Peñarrocha Diago M. Peri-implantitis: Associated microbiota and treatment. Med Oral Patol Oral Cir Bucal 2011; 16: e937-43
• 18 Mencio F, Papi P, Di Carlo S, Pompa G. Salivary bacterial leakage into implant-abutment connections: Preliminary results of an in vivo study. Eur Rev Med Pharmacol Sci 2016; 20: 2476-83
• 19 Mahmoud H, Williams DW, Hannigan A, Lynch CD. Influence of extracellular matrix proteins in enhancing bacterial adhesion to titanium surfaces.. J Biomed Mater Res B Appl Biomater 2012; 100: 1319-27
• 20 Germano F, Bramanti E, Arcuri C, Cecchetti F, Cicciù M. Atomic force microscopy of bacteria from periodontal subgingival biofilm: Preliminary study results. Eur J Dent 2013; 7: 152-8
• 21 Chang YC, Yang SF, Lai CC, Liu JY, Hsieh YS. Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures.. J Periodontal Res 2002; 37: 196-203
• 22 McKnigh H, Kelsey WP, Hooper DA, Hart TC, Mariotti A. Proteomic analyses of human gingival and periodontal ligament fibroblasts. J Periodontol 2014; 85: 810-8
• 23 Cavalla F, Osorio C, Paredes R, Valenzuela MA, García-Sesnich J, Sorsa T. et al. Matrix metalloproteinases regulate extracellular levels of SDF-1/CXCL12, IL-6 and VEGF in hydrogen peroxide-stimulated human periodontal ligament fibroblasts. Cytokine 2015; 73: 114-21
• 24 Maciejczyk M, Pietrzykowska A, Zalewska A, Knas M, Daniszewska I. The significance of matrix metalloproteinases in oral diseases. Adv Clin Exp Med 2016; 25: 383-90
• 25 Masuelli L, Pompa G, Fabrizi M, Quaranta A, Vozza I, Piccoli L. et al. Patients with peri-implantitis, unlike those with a healthy periimplant microenvironment, display antibodies to more than one heat shock protein (HSP 27, HSP 65 and HSP 90) linear epitope. Eur J Inflamm 2011; 9: 257-67
• 26 Quaranta A, Piattelli A, Scarano A, Quaranta M, Pompa G, Iezzi G. Light-microscopic evaluation of the dimensions of peri-implant mucosa around immediately loaded and submerged titanium implants in monkeys. J Periodontol 2008; 79: 1697-703
• 27 Candel-Martí ME, Flichy-Fernández AJ, Alegre-Domingo T, Ata-Ali J, Peñarrocha-Diago MA. Interleukins IL-6, IL-8, IL-10, IL-12 and periimplant disease. An update.. Med Oral Patol Oral Cir Bucal 2011; 16: e518-21
• 28 Sanz M, Chapple IL. Working Group of the VIII European Workshop on Periodontology. Clinical research on peri-implant diseases: Consensus report of Working Group 4. J Clin Periodontol 2012; 39 (Suppl. 12) 202-6
• 29 Albrektsson T, Chrcanovic B, Östman PO, Sennerby L. Initial and long-term crestal bone responses to modern dental implants. Periodontol 2000 2017; 73: 41-50
• 30 Papathanasiou E, Finkelman M, Hanley J, Parashis AO. Prevalence, etiology and treatment of peri-implant mucositis and peri-implantitis: A survey of Periodontists in the united states. J Periodontol 2016; 87: 493-501
• 31 Schminke B, Vom Orde F, Gruber R, Schliephake H, Bürgers R, Miosge N. The pathology of bone tissue during peri-implantitis. J Dent Res 2015; 94: 354-61
• 32 Klinge B, Meyle J. Working Group. Peri-implant tissue destruction. The Third EAO Consensus Conference 2012. Clin Oral Implants Res 2012; 23 (Suppl. 06) 108-10
• 33 Rakic M, Grusovin MG, Canullo L. The microbiologic profile associated with peri-implantitis in humans: A systematic review. Int J Oral Maxillofac Implants 2016; 31: 359-68
• 34 Tonetti MS, Chapple IL, Jepsen S, Sanz M. Primary and secondary prevention of periodontal and peri-implant diseases: Introduction to, and objectives of the 11th European Workshop on Periodontology consensus conference.. J Clin Periodontol 2015; 42 (Suppl. 16) S1-4
• 35 De-Gennaro LA, Lopes JD, Mariano M. Autoantibodies directed to extracellular matrix components in patients with different clinical forms of periodontitis. J Periodontol 2006; 77: 2025-30
• 36 Ejeil AL, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol 2003; 74: 188-95
• 37 Cicciù M, Herford AS, Cervino G, Troiano G, Lauritano F, Laino L. Tissue fluorescence imaging (VELscope) for quick non-invasive diagnosis in oral pathology. J Craniofac Surg 2017; 28: e112-5
• 38 Govze Y, Herzberg MC. Serum and gingival crevicular fluid anti-desmosomal antibodies in periodontitis. J Periodontol 1993; 64: 603-8
• 39 Novo E, Viera N. Antineutrophil cytoplasmic antibodies: A missing link in the pathogenesis of periodontal disease?. J Periodontal Res 1996; 31: 365-8
• 40 Séguier S, Gogly B, Bodineau A, Godeau G, Brousse N. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?. J Periodontol 2001; 72: 1398-406